SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-000293
Filing Date
2024-03-01
Accepted
2024-03-01 20:17:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4391
  Complete submission text file 0001972362-24-000293.txt   5873
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-34207 | Film No.: 24712510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DYNAVAX TECHNOLOGIES CORPORATION 2100 POWELL STREET, SUITE 1900 EMERYVILLE CA 94608
Business Address
Burgess Justin (Reporting) CIK: 0001812025 (see all company filings)

Type: 144